Concentrations of proplylacic ceftriaxone in abdominal tissues during pancreatic surgery

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 3, 1997, Pages 445-448

  Martin, Claude ^a,d   Cottin, Agnès ^b   François Godfroy, Nicole ^c   Mallet, Marie Noëlle ^b   Martin, Annie ^a   Sastre, Bernard ^a   De Micco, Philippe ^b   Gouin, François ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

^c Department of Pharmacy ^*  (France)

^d HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE;

ABDOMEN; ADIPOSE TISSUE; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BILE LEVEL; DRUG LIVER LEVEL; DRUG PENETRATION; DRUG TISSUE LEVEL; ESCHERICHIA COLI; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; PANCREAS JUICE; PANCREAS SURGERY; POSTOPERATIVE INFECTION; PROTEUS MIRABILIS; STAPHYLOCOCCUS AUREUS; ABDOMINAL WALL MUSCULATURE; BILE; CHEMISTRY; ISOLATION AND PURIFICATION; LIVER; MICROBIOLOGY; MIDDLE AGED; PANCREAS; SURGICAL INFECTION;

ABDOMINAL MUSCLES; ADIPOSE TISSUE; BILE; CEFTRIAXONE; ESCHERICHIA COLI; FEMALE; HUMANS; KLEBSIELLA PNEUMONIAE; LIVER; MALE; MIDDLE AGED; PANCREAS; PROTEUS MIRABILIS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

EID: 0030608916     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.3.445     Document Type: Article

References (10)

1. Kaiser, A. B. (1986). Antimicrobial prophylaxis in surgery. New England Journal of Medicine 315, 1129-38.
2. Martin, C. (1994). Antimicrobial prophylaxis in surgery: general concepts and clinical guidelines. French Study Group on Antimicrobial Prophylaxis in Surgery. French Society of Anesthesia and Intensive Care. Infection Control and Hospital Epidemiology 15, 463-71.
3. Brodgen, R. N. & Ward, A. (1988). Ceftriaxone: a reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. Drugs 35, 604-45.
4. Bergamini, T. M. & Polk, H. C. (1989). The importance of tissue antibiotic activity in the prevention of operative wound infection. Journal of Antimicrobial Chemotherapy 23, 301-3.
5. Martin, C., Ragni, J., Lokiec, F., Guillen, J. C., Auge, A., Pecking, M. et al. (1992). Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 mg intravenously) for antibiotic prophylaxis in thoracic surgery. Antimicrobial Agents and Chemotherapy 36, 2804-7.
6. Kosmidis, J., Stathakis, C., Mantopoulos, K., Pouriezi, T., Papathanassiou, B. & Daikos, G. K. (1980). Clinical pharmacology of cefotaxime including penetration into bile, sputum, bone and cerebrospinal fluid. Journal of Antimicrobial Chemotherapy 6, Suppl. A, 147-51.
7. Mutch, D., Richards, G., Drown, R. A. & Mulder, D. S. (1982). Bioactive antibiotic levels in the human aorta. Surgery 92, 1068-71.
8. Pitt, H. A., Roberts, R. B. & Johnson, W. D. (1973). Gentamicin levels in the human biliary tract. Journal of Infectious Diseases 127, 299-302.
9. Lorian, V. (1985). Low concentrations of antibiotics. Journal of Antimicrobial Chemotherapy 15, Suppl. A, 15-26.
10. Washington, J. A. (1979). The effects and significance of subminimal inhibitory concentrations of antibiotics. Review of Infectious Diseases 1, 781-6.